KRAS and pancreatic ductal adenocarcinoma: Our results show that the expression of alt-EJ components correlates with the development of precursor lesions of pancreatic ductal adenocarcinoma in the presence of oncogenic KRAS, and functions independently of the c-NHEJ pathway activity.